Many of the current assays for protein and peptide biomarkers that are used in the diagnosis of diabetes and in clinical diabetes research, such as C-peptide (44), insulin (45), HbA1c (46), and AABs (47), are immunoassays, which solely rely on antibody reagents. The gene discussed is INS; the disease is diabetes mellitus.